[ad_1]
Health-care companies ticked up as traders hedged their bets on the outlook for growth in the sector.
GE HealthCare shares rose sharply as the medical technology maker, spun off from conglomerate General Electric, made its stock-market debut.
Moderna struck an $85 million deal to buy closely held biotech company OriCiro Genomics.
Vera Therapeutics hit an all-time low after divulging results from a mid-stage clinical trial in a kidney-disease treatment candidate.
Write to Rob Curran at rob.curran@dowjones.com
[ad_2]
Source link
